Neurone blocker

Central neuronal blockers (reserpine) Depression, sedation, nasal congestion... [Pg.142]

Adrenalin, chloroacetyl chloride in production of, 7 142 P-Adrenergic agonists as animal growth regulators, 73 14-17 genotype, gender, and nutritional interactions related to, 73 16 mechanism of action of, 73 17 Adrenergic neuronal blockers,... [Pg.18]

An anti-hypertensive sympathetic neurone blocker debrisoquine 27... [Pg.1]

Adrenoblocking drugs are classified as a-adrenoblockers, j8-adrenoblockers, and adrenergic neuron blockers depending on the response brought about in the organism. a-Adrenoreceptors cause dilation of peripheral blood vessels, and a few of them relax smooth muscles. [Pg.161]

Conventionally called adrenergic neuron blockers, the last group of adrenoblockers are drugs that suppress synthesis, storage, and release of biogenic amines (norepinephrine, dopamine, or serotonin) in nerve endings. [Pg.162]

Adrenergic neuron blockers cause degradation of biogenic amines in neuron endings. These drugs can interfere with the synthesis, storage and release of norepinephrine, dopamine, and serotonin. [Pg.172]

Guanadrel is an adrenergic neuron blocker used for essential hypertension. The mechanism of action and side effects are similar to gnanethidine. [Pg.174]

However, a number of aj-selective adrenoblockers and adrenergic neuron blockers are used to treat hypertension. [Pg.301]

Bretylium is also an adrenergic neuron blocker which lowers blood pressure effectively, but it is also associated with unpleasant adverse reactions. [Pg.327]

This category includes ACE inhibitors, adrenergic neurone blockers, alpha-blockers, angiotensin II receptor antagonists and centrally acting vasodilatory antihypertensives. [Pg.1]

ACE INHIBITORS, ADRENERGIC NEURONE BLOCKERS, ALPHA-BLOCKERS, ANGIOTENSIN II RECEPTOR ANTAGONISTS, CENTRALLY ACTING AND VASODILATOR ANTIHYPERTENSIVES ... [Pg.34]

ADRENERGIC NEURONE BLOCKERS-GUANETHIDINE LOCAL ANAESTHETICS l clinical efficacy of guanethidine when used in the treatment of complex regional pain syndrome-type 1 The local anaesthetic i the reuptake of guanethidine Be aware. Consider use of a local anaesthetic that minimally inhibits reuptake, e.g. lidocaine when possible... [Pg.35]

ADRENERGIC NEURONE BLOCKERS-GUANETHIDINE CENTRALLY ACTING ANTIHYPERTENSIVES-METHYLDOPA MAOIs Risk of adrenergic syndrome (see above). Reports of an enhanced hypotensive effect and hallucinations with methyldopa, which may cause depression Due to inhibition of MAOI, which breaks down sympathomimetics Avoid concurrent use. Onset may be 6-24 hours after ingestion... [Pg.39]

ADRENERGIC NEURONE BLOCKERS TCAs 1 hypotensive effect. There is possibly less effect with maprotiline and mianserin TCAs compete with adrenergic neurone blockers for reuptake to nerve terminals Monitor BP at least weekly until stable... [Pg.40]

ADRENERGIC NEURONE BLOCKERS, ALPHA-BLOCKERS, CENTRALLY ACTING ANTIHYPERTENSIVES, VASODILATOR ANTIHYPERTENSIVES ASPIRIN 1 hypotensive effect not noted with low-dose aspirin Aspirin may cause sodium retention and vasoconstriction at possibly both renal and endothelial sites Monitor BP at least weekly until stable when high-dose aspirin is prescribed... [Pg.44]

ADRENERGIC NEURONE BLOCKERS PHENOTHIAZINES Variable effect some cases of t hypotensive effect other cases where hypotensive effects 1 by higher doses (> 100 mg) of chlorpromazine Additive hypotensive effect. Phenothiazines cause vasodilatation however, chlorpromazine blocks uptake of guanethidine into adrenergic neurones Monitor BP at least weekly until stable. Warn patients to report symptoms of hypotension (light-headedness, dizziness on standing, etc.)... [Pg.45]

ACE INHIBITORS, ADRENERGIC NEURONE BLOCKERS SYMPATHOMIMETICS i hypotensive effect. Note there is a risk of interactions even with topical sympathomimetics (eye and nose drops) Adrenergic neurone blockers act mainly by preventing the release of norepinephrine. Sympathomimetics stimulate adrenergic receptors, which causes a rise in BP Monitor BP at least weekly until stable... [Pg.53]

INSULIN ADRENERGIC NEURONE BLOCKERS t hypoglycaemic effect Catecholamines are diabetogenic guanethidine blocks the release of catecholamines from nerve endings Monitor blood glucose closely... [Pg.409]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...